位置:首页 > 蛋白库 > ERG5_YEAST
ERG5_YEAST
ID   ERG5_YEAST              Reviewed;         538 AA.
AC   P54781; D6VZI9; E9P965;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   03-AUG-2022, entry version 177.
DE   RecName: Full=C-22 sterol desaturase ERG5 {ECO:0000303|PubMed:8635732};
DE            EC=1.14.19.41 {ECO:0000269|PubMed:8543054, ECO:0000269|PubMed:8635732};
DE   AltName: Full=Cytochrome P450 61 {ECO:0000303|PubMed:8543054};
DE   AltName: Full=Ergosterol biosynthetic protein 5 {ECO:0000303|PubMed:8635732};
GN   Name=ERG5 {ECO:0000303|PubMed:8635732};
GN   Synonyms=CYP61 {ECO:0000303|PubMed:8543054}; OrderedLocusNames=YMR015C;
GN   ORFNames=YM9711.02C;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND
RP   PATHWAY.
RX   PubMed=8635732; DOI=10.1016/0378-1119(95)00770-9;
RA   Skaggs B.A., Alexander J.F., Pierson C.A., Schweitzer K.S., Chun K.T.,
RA   Koegel C., Barbuch R., Bard M.;
RT   "Cloning and characterization of the Saccharomyces cerevisiae C-22 sterol
RT   desaturase gene, encoding a second cytochrome P-450 involved in ergosterol
RT   biosynthesis.";
RL   Gene 169:105-109(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169872;
RA   Bowman S., Churcher C.M., Badcock K., Brown D., Chillingworth T.,
RA   Connor R., Dedman K., Devlin K., Gentles S., Hamlin N., Hunt S., Jagels K.,
RA   Lye G., Moule S., Odell C., Pearson D., Rajandream M.A., Rice P.,
RA   Skelton J., Walsh S.V., Whitehead S., Barrell B.G.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XIII.";
RL   Nature 387:90-93(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A., Raphael J.,
RA   Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F., Williamson J.,
RA   Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G., Kolodner R.D.,
RA   LaBaer J.;
RT   "Approaching a complete repository of sequence-verified protein-encoding
RT   clones for Saccharomyces cerevisiae.";
RL   Genome Res. 17:536-543(2007).
RN   [5]
RP   PROTEIN SEQUENCE OF 32-42, FUNCTION, AND CATALYTIC ACTIVITY.
RC   STRAIN=DK2;
RX   PubMed=8543054; DOI=10.1016/0014-5793(95)01342-3;
RA   Kelly S.L., Lamb D.C., Corran A.J., Baldwin B.C., Parks L.W., Kelly D.E.;
RT   "Purification and reconstitution of activity of Saccharomyces cerevisiae
RT   P450 61, a sterol delta 22-desaturase.";
RL   FEBS Lett. 377:217-220(1995).
RN   [6]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [7]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-164 AND LYS-198, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=SUB592;
RX   PubMed=12872131; DOI=10.1038/nbt849;
RA   Peng J., Schwartz D., Elias J.E., Thoreen C.C., Cheng D., Marsischky G.,
RA   Roelofs J., Finley D., Gygi S.P.;
RT   "A proteomics approach to understanding protein ubiquitination.";
RL   Nat. Biotechnol. 21:921-926(2003).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH ERG28.
RX   PubMed=15995173; DOI=10.1194/jlr.m500153-jlr200;
RA   Mo C., Bard M.;
RT   "Erg28p is a key protein in the yeast sterol biosynthetic enzyme complex.";
RL   J. Lipid Res. 46:1991-1998(2005).
RN   [9]
RP   REVIEW ON ERGOSTEROL BIOSYNTHESIS.
RX   PubMed=32679672; DOI=10.3390/genes11070795;
RA   Jorda T., Puig S.;
RT   "Regulation of ergosterol biosynthesis in Saccharomyces cerevisiae.";
RL   Genes (Basel) 11:0-0(2020).
CC   -!- FUNCTION: C-22 sterol desaturase; part of the third module of
CC       ergosterol biosynthesis pathway that includes the late steps of the
CC       pathway (PubMed:8635732, PubMed:8543054). ERG5 converts 5-
CC       dehydroepisterol into ergosta-5,7,22,24(28)-tetraen-3beta-ol by forming
CC       the C-22(23) double bond in the sterol side chain (PubMed:8635732,
CC       PubMed:8543054). The third module or late pathway involves the
CC       ergosterol synthesis itself through consecutive reactions that mainly
CC       occur in the endoplasmic reticulum (ER) membrane. Firstly, the squalene
CC       synthase ERG9 catalyzes the condensation of 2 farnesyl pyrophosphate
CC       moieties to form squalene, which is the precursor of all steroids.
CC       Squalene synthase is crucial for balancing the incorporation of
CC       farnesyl diphosphate (FPP) into sterol and nonsterol isoprene
CC       synthesis. Secondly, the squalene epoxidase ERG1 catalyzes the
CC       stereospecific oxidation of squalene to (S)-2,3-epoxysqualene, which is
CC       considered to be a rate-limiting enzyme in steroid biosynthesis. Then,
CC       the lanosterol synthase ERG7 catalyzes the cyclization of (S)-2,3
CC       oxidosqualene to lanosterol, a reaction that forms the sterol core. In
CC       the next steps, lanosterol is transformed to zymosterol through a
CC       complex process involving various demethylation, reduction and
CC       desaturation reactions. The lanosterol 14-alpha-demethylase ERG11 (also
CC       known as CYP51) catalyzes C14-demethylation of lanosterol to produce
CC       4,4'-dimethyl cholesta-8,14,24-triene-3-beta-ol, which is critical for
CC       ergosterol biosynthesis. The C-14 reductase ERG24 reduces the C14=C15
CC       double bond of 4,4-dimethyl-cholesta-8,14,24-trienol to produce 4,4-
CC       dimethyl-cholesta-8,24-dienol. 4,4-dimethyl-cholesta-8,24-dienol is
CC       substrate of the C-4 demethylation complex ERG25-ERG26-ERG27 in which
CC       ERG25 catalyzes the three-step monooxygenation required for the
CC       demethylation of 4,4-dimethyl and 4alpha-methylsterols, ERG26 catalyzes
CC       the oxidative decarboxylation that results in a reduction of the 3-
CC       beta-hydroxy group at the C-3 carbon to an oxo group, and ERG27 is
CC       responsible for the reduction of the keto group on the C-3. ERG28 has a
CC       role as a scaffold to help anchor ERG25, ERG26 and ERG27 to the
CC       endoplasmic reticulum and ERG29 regulates the activity of the iron-
CC       containing C4-methylsterol oxidase ERG25. Then, the sterol 24-C-
CC       methyltransferase ERG6 catalyzes the methyl transfer from S-adenosyl-
CC       methionine to the C-24 of zymosterol to form fecosterol. The C-8 sterol
CC       isomerase ERG2 catalyzes the reaction which results in unsaturation at
CC       C-7 in the B ring of sterols and thus converts fecosterol to episterol.
CC       The sterol-C5-desaturase ERG3 then catalyzes the introduction of a C-5
CC       double bond in the B ring to produce 5-dehydroepisterol. The C-22
CC       sterol desaturase ERG5 further converts 5-dehydroepisterol into
CC       ergosta-5,7,22,24(28)-tetraen-3beta-ol by forming the C-22(23) double
CC       bond in the sterol side chain. Finally, ergosta-5,7,22,24(28)-tetraen-
CC       3beta-ol is substrate of the C-24(28) sterol reductase ERG4 to produce
CC       ergosterol (PubMed:32679672). {ECO:0000269|PubMed:8543054,
CC       ECO:0000269|PubMed:8635732, ECO:0000303|PubMed:32679672}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5-dehydroepisterol + H(+) + NADPH + O2 = ergosta-
CC         5,7,22,24(28)-tetraen-3beta-ol + 2 H2O + NADP(+);
CC         Xref=Rhea:RHEA:33467, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:18249, ChEBI:CHEBI:52972,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.14.19.41;
CC         Evidence={ECO:0000269|PubMed:8543054, ECO:0000269|PubMed:8635732};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33468;
CC         Evidence={ECO:0000269|PubMed:8543054, ECO:0000269|PubMed:8635732};
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000250|UniProtKB:P04798};
CC   -!- PATHWAY: Steroid metabolism; ergosterol biosynthesis; ergosterol from
CC       zymosterol: step 4/5. {ECO:0000269|PubMed:8635732}.
CC   -!- SUBUNIT: Interacts with ERG28. {ECO:0000269|PubMed:15995173}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305};
CC       Single-pass membrane protein {ECO:0000255}.
CC   -!- MISCELLANEOUS: Present with 24700 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U34636; AAB06217.1; -; Genomic_DNA.
DR   EMBL; Z49211; CAA89116.1; -; Genomic_DNA.
DR   EMBL; AY723852; AAU09769.1; -; Genomic_DNA.
DR   EMBL; BK006946; DAA09913.1; -; Genomic_DNA.
DR   PIR; S54015; S54015.
DR   RefSeq; NP_013728.1; NM_001182511.1.
DR   AlphaFoldDB; P54781; -.
DR   SMR; P54781; -.
DR   BioGRID; 35186; 247.
DR   IntAct; P54781; 16.
DR   MINT; P54781; -.
DR   STRING; 4932.YMR015C; -.
DR   iPTMnet; P54781; -.
DR   MaxQB; P54781; -.
DR   PaxDb; P54781; -.
DR   PRIDE; P54781; -.
DR   EnsemblFungi; YMR015C_mRNA; YMR015C; YMR015C.
DR   GeneID; 855029; -.
DR   KEGG; sce:YMR015C; -.
DR   SGD; S000004617; ERG5.
DR   VEuPathDB; FungiDB:YMR015C; -.
DR   eggNOG; KOG0157; Eukaryota.
DR   HOGENOM; CLU_023517_0_0_1; -.
DR   InParanoid; P54781; -.
DR   OMA; MVIPSFY; -.
DR   BioCyc; MetaCyc:MON3O-232; -.
DR   BioCyc; YEAST:MON3O-232; -.
DR   BRENDA; 1.14.19.41; 984.
DR   UniPathway; UPA00768; UER00763.
DR   PRO; PR:P54781; -.
DR   Proteomes; UP000002311; Chromosome XIII.
DR   RNAct; P54781; protein.
DR   GO; GO:0005783; C:endoplasmic reticulum; HDA:SGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0000249; F:C-22 sterol desaturase activity; IDA:SGD.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; IEA:InterPro.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0006696; P:ergosterol biosynthetic process; IDA:SGD.
DR   GO; GO:0016125; P:sterol metabolic process; IBA:GO_Central.
DR   Gene3D; 1.10.630.10; -; 1.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002403; Cyt_P450_E_grp-IV.
DR   InterPro; IPR036396; Cyt_P450_sf.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00465; EP450IV.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Endoplasmic reticulum; Heme; Iron;
KW   Isopeptide bond; Lipid biosynthesis; Lipid metabolism; Membrane;
KW   Metal-binding; NADP; Oxidoreductase; Reference proteome;
KW   Steroid biosynthesis; Steroid metabolism; Sterol biosynthesis;
KW   Sterol metabolism; Transmembrane; Transmembrane helix; Ubl conjugation.
FT   CHAIN           1..538
FT                   /note="C-22 sterol desaturase ERG5"
FT                   /id="PRO_0000052050"
FT   TRANSMEM        46..66
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   BINDING         476
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000250|UniProtKB:P04798"
FT   CROSSLNK        164
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:12872131"
FT   CROSSLNK        198
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:12872131"
FT   CONFLICT        286
FT                   /note="I -> T (in Ref. 4; AAU09769)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   538 AA;  61334 MW;  2CE8DC6CE0315AC3 CRC64;
     MSSVAENIIQ HATHNSTLHQ LAKDQPSVGV TTAFSILDTL KSMSYLKIFA TLICILLVWD
     QVAYQIKKGS IAGPKFKFWP IIGPFLESLD PKFEEYKAKW ASGPLSCVSI FHKFVVIAST
     RDLARKILQS SKFVKPCVVD VAVKILRPCN WVFLDGKAHT DYRKSLNGLF TKQALAQYLP
     SLEQIMDKYM DKFVRLSKEN NYEPQVFFHE MREILCALSL NSFCGNYITE DQVRKIADDY
     YLVTAALELV NFPIIIPYTK TWYGKKTADM AMKIFENCAQ MAKDHIAAGG KPVCVMDAWC
     KLMHDAKNSN DDDSRIYHRE FTNKEISEAV FTFLFASQDA SSSLACWLFQ IVADRPDVLA
     KIREEQLAVR NNDMSTELNL DLIEKMKYTN MVIKETLRYR PPVLMVPYVV KKNFPVSPNY
     TAPKGAMLIP TLYPALHDPE VYENPDEFIP ERWVEGSKAS EAKKNWLVFG CGPHVCLGQT
     YVMITFAALL GKFALYTDFH HTVTPLSEKI KVFATIFPKD DLLLTFKKRD PITGEVFE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024